Skip to main content
. 2019 May 21;10(36):3339–3351. doi: 10.18632/oncotarget.26917

Figure 6. Schematic representation of pre- and post-application of NF-κB inhibitor (BAY 11-7082) in acidic bile-exposed MHPC.

Figure 6